Will Negative-Beta Stocks Help Outperform the TSX?

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has seen returns of over 4% year to date, while the TSX has seen losses.

| More on:

Beta is a measure of risk; specifically, it’s how risky a stock is in relation to the market. A beta of more than one indicates a stock has larger swings than the market, and a beta of less than one indicates it has less volatile swings. A negative beta, however, suggests that the stock moves in the opposite direction of the index. Beta can change over time, and one financial website can calculate beta over a different period of time than another website. It can be a moving target, so it is important to understand why there might be fluctuations or differences in it.

Alimentation Couche Tard Inc. (TSX:ATD.B) has a beta of -0.36, and year-to-date returns have been down over 2%, while the TSX has returned a loss of 0.90%. If we look at a broader range, 12 months, then Couche Tard has a positive return of 1%, but it is still less than the almost 4% the TSX has brought in. We need to look at the five-year window before we see the stock outperform the TSX, with its return climbing to 277% compared to just 28% for the market.

In the short term, Couche Tard has not provided investors with much security over the TSX and has actually performed worse. In the long term, the stock’s performance has been due in large part to its successful sales and profit growth over the years, and during that time its beta may have looked much different.

Waste Connections Inc. (TSX:WCN)(NYSE:WCN) also has a negative beta of -0.14 listed for its stock. Year to date, this stock has been up over 15% and almost 25% in the past 12 months. In this case, the negative-beta stock has vastly outperformed the TSX. If we extend the outlook to five years, then the gap is even wider, with Waste Connections yielding a total return of over 185%.

Waste Connections is a winner in all time frames and could be a good stock to rely on outperform the TSX.

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) lists a high negative beta of -0.81 and, year to date, has seen returns of just over 4%. However, in the past 12 months, the stock has been much worse than the TSX, losing over 30% in value. In the past five years, the stock has declined by over 50%. The only time frame Valeant has proven to beat the TSX is during the short term.

The problem with this analysis is that Valeant’s stock has seen a significant tumble due to its own doing and internal problems. The recent outperformance of the TSX may have had more to do with the stock reaching a bottom rather than having a tendency to go in the opposite direction of the market.

With the exception of Waste Connections, the stocks here have not proven to be more helpful in beating the TSX, especially in the short term. The one reason Waste Connections may be able to ignore the TSX’s overall impact is because the company is effectively recession-proof; the company’s services are needed regardless of whether the economy is doing well or not.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any stocks mentioned. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals. Alimentation Couche Tard is a recommendation of Stock Advisor Canada.

More on Dividend Stocks

bulb idea thinking
Dividend Stocks

The Smartest Dividend Stocks to Buy With $500 Right Now

Investing in top dividend stocks such as Brookfield Renewable can help long-term shareholders create a growing recurring income stream.

Read more »

Blocks conceptualizing Canada's Tax Free Savings Account
Dividend Stocks

TFSA 101: Earn $1,430 Per Year Tax-Free

Are you new to the TFSA? Here are three strategies to optimize its tax benefits to earn annual passive tax-free…

Read more »

concept of real estate evaluation
Dividend Stocks

Buy 1,154 Shares of This Top Dividend Stock for $492.54/Month in Passive Income

This dividend stock can pay out top cash every month, sure, but has even more to look forward to.

Read more »

TFSA (Tax free savings account) acronym on wooden cubes on the background of stacks of coins
Dividend Stocks

How to Use a TFSA to Create $1,650 in Passive Income for Decades! 

If you spend a lot, consider the dividend route to create a passive income for decades. The TFSA can be…

Read more »

Hourglass and stock price chart
Dividend Stocks

This 7.1% Dividend Stock Pays Cash Every Month

This dividend stock is a solid choice for investors looking for long-term cash from the healthcare sector, with monthly dividends…

Read more »

hand stacks coins
Dividend Stocks

Should You Buy the 3 Highest-Paying Dividend Stocks in Canada?

Let's get into the highest of the high, not by dividend yield, but the payments you can bring in each…

Read more »

Canadian stocks are rising
Dividend Stocks

2 No-Brainer Real Estate Stocks to Buy Right Now for Less Than $500 

Do you have $500 and are wondering which stocks to buy? These no-brainer real estate stocks could be good additions…

Read more »

A train passes Morant's curve in Banff National Park in the Canadian Rockies.
Dividend Stocks

Is Canadian National Railway a Buy for its 2.25% Dividend Yield?

CNR's dividend yield is looking juicy. Does this mean it's a buy?

Read more »